Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 July 2021 | Story Leonie Bolleurs | Photo UFS Photo Archive
Prof Hendrik Swart played a key role in the Department of Physics acquiring the PHI Quantes XPS system, the first in Africa and one of only 20 in the world.

The state-of-the-art equipment in the Department of Physics at the University of the Free State (UFS) differentiates this department from its competitors. Availability of the equipment makes it possible for researchers as well as students to deliver work that receives national and international recognition. 

Recently, the department acquired a PHI Quantes XPS system, the first in Africa and one of only 20 in the world. 

Creating better phosphor 

“The Quantes XPS system uses X-rays to determine the chemical composition of molecules on the surface of a sample. The system is unique in the sense that it also has an extra X-ray source that can determine the chemical state below the surface, which was not possible in the past.  This will help us to dictate the position of defects in our phosphor materials that will consequently enable us to create better phosphor for solid state lighting as well as solar cell applications,” explains Prof Hendrik Swart, Senior Professor in the Department of Physics, who also holds the SARChI Chair in Solid State Luminescent and Advanced Materials.

After he had the opportunity to observe the system in the factory in Chigasaki, Kanagawa, Japan, where he attended a conference, Prof Swart was very impressed by its performance. He discussed it with Prof Koos Terblans, Head of the department, and other colleagues, and started making plans to buy the system. 

When the department first bought the X-ray photoelectron spectroscopy (XPS) system in 2007/2008, it became the national facility on XPS measurements. Not only is this an upgrade of the XPS system bought 14 years ago, but the new system will enable the department to do more measurements. “The number of samples that we have to handle has just become too much for one system. The new system’s increased capacity for making measurements addresses this challenge and it also gives UFS scientists and postgraduate students more time to spend on fundamental measurements to develop research of a higher level,” says Prof Swart.

(The Quantes XPS system. Photo:Supplied)

Explaining about the measurements, Prof Swart says: “This advanced X-ray photoelectron spectroscopy (XPS) instrument has the capability to analyse the very small area that the user is interested in and a large area of the uniform sample surface. The two different types of X-ray sources – the hard X-ray source and the more conventional soft X-ray source – can be switched automatically, allowing users to analyse the same area and/or points of a sample. The PHI Quantes XPS system ensures the availability of superior features such as automatic analysis, automatic sample transfer, turnkey charge neutralisation, and advanced data processing.”

“This XPS instrument is designed to pioneer new methods and applications transcending conventional ideas of what is possible.”

Optimising efficiency of materials

Prof Swart says the Department of Physics, especially the Research Chair in Advanced and Luminescent Materials, is developing new high-technology materials on a daily basis. “It is very important to know the chemical composition and defect distribution of the materials in order to add value to the fabrication of these materials,” he adds.

“The distribution of these defects is vital for the efficiency of the phosphor materials. If we know where these defects are located, we can determine the mechanisms of the light output coming from these phosphors,” describes Prof Swart.

Research conducted as part of the Research Chair in Solid State Luminescent and Advanced Materials will benefit significantly from this new system.

(Prof Koos Terblans, Head of the Department of Physics next to the Quantes XPS system. Photo:Supplied) 

“We are currently concentrating on phosphors as sensors (temperature), light-emitting diodes (LEDs), and solar cells, where we optimise the efficiency and durability of these materials. Any new knowledge, which I believe the PHI Quantes XPS system will provide us, will help us to reach our goal much quicker,” he says. 

Apart from the positive impact on research, the PHI Quantes XPS system will also be a benefit to society in the long term. Improved LEDs can be used to save electricity, and better solar cells can help to generate electricity, to mention but two examples. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept